Multiplex assay improves species-specific parasite diagnosis

"These data provide a new framework for clinically useful parasite-specific serology that helps to direct targeted therapeutic options."

By
Matthew Solan
August 17, 2026
5 min

MDSpire News

Overview

A multiplex immunoassay using recombinant antigens achieved species-specific serodiagnosis for 80% of seropositive samples from travelers and immigrants evaluated for filarial infections or strongyloidiasis. The assay demonstrated high specificity and sensitivity for multiple parasitic infections.

Background

Accurate diagnosis of filarial infections and strongyloidiasis is crucial for effective treatment, especially in travelers and immigrants from endemic regions. Traditional diagnostic methods may lack specificity and sensitivity, leading to misdiagnosis and inappropriate treatment.

Data Highlights

Antigen	Specificity	Sensitivity (IgG)	Sensitivity (IgG4)
Ll-SXP1 (L. loa)	98.7%	87.5%	85.3%
Wb123 (W. bancrofti)	99.7%	95%	89%
Wb5 (W. bancrofti)	99.9%	65%	53.4%
OvOC3261 (O. volvulus)	99.5%	78%	87.2%
Ov16 (O. volvulus)	99.7%	84%	82%
Ss-NIE (S. stercoralis)	99.9%	74.7%	77.9%
Ss-IR (S. stercoralis)	99.7%	84.6%	60.5%

Key Findings

The multiplex assay provided a species-specific serodiagnosis for 80% of seropositive samples.
High specificity (>98%) was achieved for all recombinant antigens tested.
Coinfection was identified in 10% of seropositive samples.
20% of seropositive samples showed filarial antibody reactivity without a determined infecting species.
IgG and IgG4 responses were measured simultaneously, enhancing diagnostic accuracy.